University

EPFL-backed Foundation for Technology Innovation has appointed David Kappeler as director and head of investments.

Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.

Quentin Compton-Bishop has resigned as CEO of Warwick Ventures, but said he would continue to be involved in university venturing.

Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

CSU Ventures boosted its licensing income by more than two-fold and established six new spinouts during the 2018-19 academic year.

Huawei has been revealed as an LP in Oxford Sciences Innovation, having made its investment late last year before the university decided to block the corporate from philanthropic donations.

Lessons from the GUV Summit in Houston, Texas, this month

Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.

Editor Thierry Heles sits down with David Grimm (pictured), manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.

As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.